Psychiatry and Clinical Psychopharmacology

Empyema in a Patient with Schizophrenia Using Clozapine: A Case Report


Department of Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea


Department of Psychiatry, College of Medicine, Kyung Hee University, Seoul, Republic of Korea

Psychiatry and Clinical Psychopharmacology 2022; 32: 184-187
DOI: 10.5152/pcp.2022.22314
Read: 411 Downloads: 179 Published: 01 June 2022

Schizophrenia is associated with a high risk of thoracic infections and pneumonia. The use of atypical antipsychotics clozapine may also increase the risk of pulmonary infection. However, psychotic patients are less likely to report physical symptoms, and these dangerous conditions may go undetected. In this case report, we present 47-year-old woman with schizophrenia who had been using clozapine and did not complain of respiratory symptoms. After admission, she was diagnosed with streptococcus intermedius empyema. Although empyema has a high mortality rate, thanks to the timely admission and proper diagnosis, the patient recovered after 3 weeks of medical and surgical treatment.

Cite this article as: Park YJ, Lee SM, Kang WS. Empyema in a patient with schizophrenia using clozapine: A case report. Psychiatry Clin Psychopharmacol. 2022;32(2):184-187.

EISSN 2475-0581